A recent retrospective cohort study looked at GLP-1 adherence in patients with obesity and with/without diabetes: Those with T2DM: 46.5% discontinued by year one 64.1% discontinued by year two Those without T2DM: 64.8% discontinued by year one 84.4% discontinued by year two So yes access is a problem
Every person is different, and what works best for you depends on your specific situation, preferences, and health goals
Muscle, movement, and body composition Exercise is one of the most consistent signals in dementia-prevention research, but it should not be reduced to step counts
The SEMALEAN trial found lean mass declined then stabilised while handgrip strength improved by 4.5 kg and sarcopenic obesity prevalence fell from 49% to 33% over twelve months
Different brands of GLP-1 have different prices
To avoid a possible effect of food and water intake and physical activity, the meal plan and total daily fluid intake as well as physical activeness were kept constant during the study and the patients received a dietary advice with provided by a renal dietitian before the study commenced